Clinical Trial Update: Partnership for Research on Ebola VACcinations [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results for an Ebola vaccine collaboration have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Ebola Virus Disease | Phase 2 | Status: COMPLETED | Results posted: 2022-09-28